Clinical trial
Evaluation of Effectiveness and Safety of XIENCE Xpedition/Alpine/Sierra in Routine Clinical Practice; A MULTICENTER, PROSPECTIVE OBSERVATIONAL STUDY
NCT02042300 is registered in ClinicalTrials.gov with Seung-Jung Park as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Effectiveness and Safety of XIENCE Xpedition/Alpine/Sierra in Routine Clinical Practice; A MULTICENTER, PROSPECTIVE OBSERVATIONAL STUDY
- Lead sponsor
- Seung-Jung Park
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2014
- Completion date
- August 30, 2024
- Enrollment
- 4,000 (actual)
- Sites
- 26
Conditions
As the registry lists them; a condition with its own page is linked.
coronary artery disease, percutaneous transluminal coronary angioplasty